News

"It's more of, 'What do we build?'" Researchers make incredible breakthrough that could solve major issue in medical industry: 'Unprecedented' first appeared on The Cool Down.
Technology can be harnessed to design novel and enhanced molecules that address challenges in biotechnology or medicine.
Inhaled insulin is effective for controlling blood sugar levels in children with diabetes, providing them with a ...
What is the difference between Type 1 and Type 2 diabetes? What about pre-diabetes? And how does insulin resistance factor in? Here's what to know.
S, the best course of action is to correct the energy imbalance by managing nutrition and training, and in these cases, meds ...
Shane Tews is joined by Father Paolo Benanti, a theologian and ethicist for the Vatican on AI, for a thought-provoking interactive discussion that transcends traditional debates on values and policy ...
VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a Phase 1/2 study. Gene ...
UCSF researchers recently created the world's first shape-shifting synthetic proteins using artificial intelligence (AI). The breakthrough opens the door to developing entirely new proteins that could ...
A ‘digital twin’ for diabetes control While automated insulin delivery systems like the artificial pancreas help users better manage Type 1 diabetes, adaptive biobehavioral control technology is ...
A group of researchers at the University of British Columbia says they are one step closer to developing a pill that could deliver insulin as effectively as an injection.
A common artificial sweetener may trigger insulin spikes that lead to the build up of fatty plaques in the arteries, increasing the risk of heart attacks and strokes, a new study in mice indicates.
If California patients pay more than $35 per month for insulin now, it’s in large part because PBMs have rigged the system in their favor.